Arctic Bioscience Investor Relations Material
Latest events
Q2 2023
Arctic Bioscience
Access the full event backlog
Slides, Transcripts, and Reports from over 8,000 public companies
Arctic Bioscience AS is a biotechnology company that develops, manufactures and commercializes pharmaceutical products in Norway. Arctic Bioscience's proprietary technology platform includes a unique lipid-based adjuvant based on Algal oil derived from microalgae, carbon dioxide fixing organisms and proprietary delivery systems for use in combination with generic vaccine antigens. Arctic Bioscience AS was incorporated in 2011 and is based in Ørsta, Norway.
Key slides for Arctic Bioscience
Q2 2023
Arctic Bioscience
Q2 2023
Arctic Bioscience
Latest articles
Marvel-ous Reporting: Marvel’s Comic Inspired Reports
Shareholder reports are often considered tedious and dry. However, in the late 1980s and early 1990s, Marvel Comics revolutionized this perception by transforming its financial reports into captivating comic books.
8 Dec 2023
The Payments Value Chain: A Complex Ecosystem
The payments industry is a complex and dynamic field involving multiple key players. These include customers, merchants, issuers, acquirers, card networks, and various other entities together forming the payments value chain.
8 Dec 2023
NIBE: Creating Millionaires and a Greener Future
NIBE, just like IKEA, was founded in a rural part of Sweden called Småland. The company offers a wide range of pumps, wood stoves, and solar panels.
6 Dec 2023
Ticker symbol
ABS
Country
🇳🇴 Norway